Celltrion has received permission from the Food and Drug Administration for Stoboclo (CT-P41, denosumab-bmwo) and Osenvelt ...
US FDA approves Celltrion’s Stoboclo and Osenvelt biosimilars referencing Prolia and Xgeva: Jersey City, New Jersey Wednesday, March 5, 2025, 18:00 Hrs [IST] Celltrion, a leadin ...
Leading pharmaceutical associations in Russia have called on the government to postpone the introduction of new procurement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback